Skip to main content
Rise up! Award for Özgün Göcke

Honors & Funding

Özgün Göcke receivs Rise up! Award 2024

The Rise up! programme is aimed at outstanding and unusually creative basic researchers from the fields of biology, chemistry and medicine who have accepted a W2 professorship at a German university for the first time. The award is endowed with up to 600,000 euros each. 

The Boehringer Ingelheim Foundation recently awarded ImmunoSensation2 member Prof Özgün Gökce with the Rise up! award 2024. Göcke heads the ‘Systems Neuroscience - Cell Diversity’ working group at the Department of Neurodegenerative Diseases and Gerontopsychiatry at the UKB. The neurobiologist is looking for the key to the mechanisms of brain ageing. To this end, he plans to use new spatial transcriptomics technologies to investigate the basic principles of the nervous system in both healthy and diseased states. His project focuses on investigating how lipids alter and modulate adaptive and innate immune responses in the context of ageing and neurodegeneration.

 

Contact

Prof. Özgün Göcke

Medical Faculty, University of Bonn

& German Center for Neurodegenerative Diseases

mail: Ozgun.Goekce@ukbonn.de

 


 

 

Related news

Sieglinde Tyczka und Frederick Tyczka-Christoph zu Besuch in der Bonner Universitäts-Augenklinik. - von links: Prof. Dr. Uwe Reuter, Vorstandsvorsitzender und Ärztlicher Vorstand des UKB, Frederick Tyczka-Christoph, Sieglinde Tyczka, Prof. Dr. Frank G. Holz, Direktor der Augenklinik am UKB.

Honors & Funding

One Million Euros for Restoring Vision in Age-Related Macular Degeneration

—The Tyczka family of entrepreneurs is supporting research into restoring vision in patients with age-related macular degeneration (AMD) with a donation of one million euros. The funding will support the research project “AI-supported optimisation of vision restoration using retinal implants” at the Department of Ophthalmology at Bonn University Hospital (UKB). The aim of the project is to further develop and optimise the application of innovative retinal implant technology, which recently received European CE marking as a medical device.
View entry
25 Millionen Euro für die Bonner KI-Krebsforschung: (v.l.) Prof. Dr. Bernd Weber, Prof. Dr. Michael Hölzel, Prof. Dr. Jürgen Bajorath und Prof. Dr. Uwe Reuter, beim Auftakt von AI4CancerCure.NRW in der Staatskanzlei Nordrhein-Westfalen.

Honors & Funding

€25 Million for AI-Powered Cancer Research in Bonn

—University Hospital Bonn (UKB), the University of Bonn and the Lamarr Institute for Machine Learning and Artificial Intelligence are using funding from the state of North Rhine-Westphalia to establish a joint research infrastructure. The aim is to use AI to design and optimize potential cancer therapeutics and subsequently test them in the laboratory. Minister-President Hendrik Wüst and Minister of Science Ina Brandes presented the funding commitment today at the State Chancellery of North Rhine-Westphalia.
View entry
Prof. Dr. Frank G. Holz – Director of the Department of Ophthalmology at the University Hospital Bonn (UKB) and Professor at the University of Bonn.

Honors & Funding

Frank Holz Nominated for the Science Breakthrough of the Year 2026

—A remarkable achievement for the Faculty of Medicine at the University of Bonn: Prof. Dr. Frank G. Holz, Director of the Department of Ophthalmology at the UKB and Professor at the University of Bonn, has been shortlisted for the Falling Walls Science Breakthrough of the Year 2026 in the Life Sciences category. His project is now among the 30 most outstanding scientific innovations worldwide in this category, recognized by the prestigious Falling Walls Science Summit. Being shortlisted alone represents a significant international distinction.
View entry

Back to the news overview